1.
Metal homeostasis in infectious disease: recent advances in bacterial metallophores and the human metal-withholding response.
Neumann, W, Gulati, A, Nolan, EM
Current opinion in chemical biology. 2017;:10-18
-
-
Free full text
-
Abstract
A tug-of-war between the mammalian host and bacterial pathogen for nutrients, including first-row transition metals (e.g. Mn, Fe, Zn), occurs during infection. Here we present recent advances about three metal-chelating metabolites that bacterial pathogens deploy when invading the host: staphylopine, staphyloferrin B, and enterobactin. These highlights provide new insights into the mechanisms of bacterial metal acquisition and regulation, as well as the contributions of host-defense proteins during the human innate immune response. The studies also underscore that the chemical composition of the microenvironment at an infection site can influence bacterial pathogenesis and the innate immune system.
2.
[Effect of zinc amino acid chelate and zinc sulfate in the incidence of respiratory infection and diarrhea among preschool children in child daycare centers].
Sánchez, J, Villada, OA, Rojas, ML, Montoya, L, Díaz, A, Vargas, C, Chica, J, Herrera, AA
Biomedica : revista del Instituto Nacional de Salud. 2014;(1):79-91
Abstract
INTRODUCTION Zinc deficiency is common in children among populations in developing areas. Zinc deficiency alters the immune system and the resistance to infections. OBJECTIVE To evaluate the effect of two zinc compounds in the prevention of acute respiratory infection and acute diarrhea. MATERIALS AND METHODS Randomized triple-blind community trial with 301 children between 2-5 years of age from six child daycare centers in Medellin, Colombia. Children were distributed in three groups receiving zinc amino acid chelate, zinc sulfate and placebo five days a week for 16 weeks. Daily symptoms of respiratory infection, acute diarrhea and side effects were evaluated. RESULTS The incidence of respiratory infection was lower with zinc amino acid chelate (1.42 per 1,000 child-days) compared with placebo (3.3 per 1,000 child-days) (RR=0.43, 95% CI: 0.196 to 0.950, p=0.049) and with zinc sulfate (1.57 per 1,000 child-days) (RR=0.90, 95% CI 0.382 to 2.153, p=0.999). The incidence of acute diarrhea with zinc amino acid chelate (0.15 per 1,000 child-days) was lower than with placebo (0.49 per 1,000 child-days) (RR=0.32, 95% CI 0.006 to 3.990, p=0.346) and with zinc sulfate (0.78 per 1,000 child-days) (RR=0.20, 95% CI: 0.0043 to 1.662, p=0.361). CONCLUSIONS Zinc amino acid chelate had a better effect in reducing the incidence of acute respiratory infection and acute diarrhea in preschool children when compared with the other groups.